| 1 | The role of the glutamine transporter ASCT2 in antineoplastic therapy. 2021;87:447 doi: 10.1007/s00280-020-04218-6 |
| 2 | Mitochondrial uncoupling and the disruption of the metabolic network in hepatocellular carcinoma. 2020;11:3013 doi: 10.18632/oncotarget.27680 |
| 3 | Next-Generation Molecular Imaging of Thyroid Cancer. 2021;13:3188 doi: 10.3390/cancers13133188 |
| 4 | Tumor Microenvironment. 2020;1219:297 doi: 10.1007/978-3-030-34025-4_15 |
| 5 | Alloferon Affects the Chemosensitivity of Pancreatic Cancer by Regulating the Expression of SLC6A14. 2022;10:1113 doi: 10.3390/biomedicines10051113 |
| 6 | Glutaminolysis dynamics during astrocytoma progression correlates with tumor aggressiveness. 2021;9: doi: 10.1186/s40170-021-00255-8 |
| 7 | Redox Potential of Antioxidants in Cancer Progression and Prevention. 2020;9:1156 doi: 10.3390/antiox9111156 |
| 8 | A Metabolomics-Based Screening Proposal for Colorectal Cancer. 2022;12:110 doi: 10.3390/metabo12020110 |
| 9 | Glutamine promotes escape from therapy-induced senescence in tumor cells. 2021;13:20962 doi: 10.18632/aging.203495 |
Cancer Drug Resistance
